Formoterol in clinical practice—safety issues
- 31 August 2001
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 95, S21-S25
- https://doi.org/10.1053/rmed.2001.1142
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The evolution of β2-agonistsRespiratory Medicine, 2001
- Oxis®(formoterol given by Turbuhaler®) showed as rapid an onset of action as salbutamol given by a pMDIRespiratory Medicine, 2000
- Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstrictionEuropean Respiratory Journal, 1999
- Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severityJournal of Allergy and Clinical Immunology, 1999
- Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potencyEuropean Respiratory Journal, 1997
- SalmeterolMedicinal Research Reviews, 1995
- Comparison of the Effects of Salmeterol and Formoterol on Airway Tone and Responsiveness over 24 Hours in Bronchial AsthmaAmerican Review of Respiratory Disease, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990
- Salbutamol in the 1980sDrugs, 1989